Trademark: 79320671
Word
SCIRENT CLINICAL RESEARCH AND SCIENCE
Status Date
Tuesday, October 11, 2022
Registration Number
6868383
Registration Date
Tuesday, October 11, 2022
Filing Date
Wednesday, April 21, 2021
Published for Opposition
Tuesday, July 26, 2022
42 Medical and scientific research and data analysis services; implementation and analysis of clinical trials in the field of medicines, medical devices, biotechnology and natural sciences; development of protocols, scientific consultation, and preparation of reports with respect to medical research; research center project management; local and global clinical trial project management; pharmaceutical drug development services, development of clinical trial methodologies; consultancy services in the field of pharmaceutical clinical trials; extensive clinical research services for others; electronic storage services for clinical trial data; biostatic analysis; services provided by consultants with respect to research in the field of environmental protection, preclinical research and evaluation of pharmaceutical product development; conducting clinical trials for others in the nature of scientific research, especially the correction of clinical trials and defective records; clinical trial services in the nature of strategic management of clinical research portfolios and follow-up of biological monitoring; providing information in the field of natural sciences and scientific research to physicians and other health professionals, to patients and to medical, pharmaceutical and biotechnological companies; providing technical drafting services for complaints and/or disputes in the field of medical research and clinical studies; consultation services in the field of clinical research under contract and product development under contact; design and development of computer hardware as well as consultation services relating thereto for others; creating websites featuring blogs on medical and pharmaceutical information relating to chronic conditions and diseases; creating and maintaining Internet websites for patients and registered care providers to form virtual communities and to engage in the field of health; design and development of an interactive software for use in the communication and dissemination of medical and pharmaceutical information
The sign consists of the word SCIRENT, in Latin capital letters, in black. Below the word SCIRENT, there are four words - Clinical Research and Science, in Latin letters, in blue. In the upper right corner, above the word SCIRENT there is a circle in different shades of green and blue (light green, dark green, light blue, dark blue) whose center is painted in white
The color(s) white, black, blue and green is/are claimed as a feature of the mark.
"CLINICAL RESEARCH AND SCIENCE"
Mar 21, 2023
Final Decision Transaction Processed By Ib
Jan 30, 2023
Generic Madrid Transaction Sent To Ib
Jan 30, 2023
Generic Madrid Transaction Created
Jan 11, 2023
Final Disposition Notice Created, To Be Sent To Ib
Oct 11, 2022
Notice Of Registration Confirmation Emailed
Oct 11, 2022
Registered-Principal Register
Jul 26, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 26, 2022
Published For Opposition
Jul 25, 2022
Notification Processed By Ib
Jul 7, 2022
Notification Of Possible Opposition Sent To Ib
Jul 6, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jul 6, 2022
Notification Of Notice Of Publication E-Mailed
Jun 22, 2022
Approved For Pub - Principal Register
Jun 4, 2022
Teas/Email Correspondence Entered
Jun 4, 2022
Correspondence Received In Law Office
Jun 4, 2022
Teas Response To Office Action Received
Feb 6, 2022
Refusal Processed By Ib
Jan 18, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jan 18, 2022
Refusal Processed By Mpu
Dec 23, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Dec 22, 2021
Non-Final Action Written
Dec 15, 2021
Assigned To Examiner
Oct 1, 2021
Application Filing Receipt Mailed
Sep 27, 2021
New Application Office Supplied Data Entered
Sep 16, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
